Is admission under observation and possible termination of pregnancy warranted for a 34-week gestation with abnormal fetal surveillance findings, including decreased beat-to-beat variation on cardiotocography (CTG) and abnormal Doppler indices?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Assessment of Ultrasound Report and Management Plan for 34-Week Gestation with Abnormal Fetal Surveillance

Critical Analysis of the Reported Doppler Values

The reported umbilical artery Doppler indices (RI 0.69, S/D ratio 3.2) are actually NORMAL for 34 weeks gestation, and the management plan describing these as "abnormal" and "increased" is incorrect. 1

  • Normal umbilical artery S/D ratio at 34 weeks is typically less than 3.0, but values up to 3.2 remain within acceptable limits for this gestational age 1
  • The RI of 0.69 falls within the normal range for third trimester pregnancies 1
  • The report's assertion that "normal at this age less than 3" for S/D ratio is overly stringent and does not align with established reference ranges 1

Primary Concern: Decreased Beat-to-Beat Variability on CTG

The admission is justified based on the decreased beat-to-beat variability on cardiotocography that failed to improve with resuscitative measures, NOT based on the Doppler findings. 2

Appropriate Management of Category 2 CTG Pattern

  • Decreased beat-to-beat variability represents a Category 2 (indeterminate) fetal heart rate pattern requiring increased surveillance 2
  • The interventions attempted (IV fluids, left lateral position, oxygen) were appropriate initial resuscitative measures 2
  • Admission for observation with serial fetal surveillance is warranted when Category 2 patterns persist despite resuscitative efforts 2

Recommended Surveillance Protocol

  • For Category 2 CTG at 34 weeks with normal umbilical artery Doppler, increase monitoring frequency to at least twice weekly 2, 3
  • Continue daily cardiotocography monitoring during inpatient observation 2
  • Repeat biophysical profile assessment, as the BPP is more specific than sensitive for identifying fetal compromise 1
  • Consider additional Doppler evaluation of middle cerebral artery and ductus venosus to assess for cerebral redistribution or venous compromise 1

Delivery Timing Considerations

At 34 weeks with normal umbilical artery Doppler and persistent Category 2 CTG, expectant management with intensive surveillance is appropriate rather than immediate delivery. 2, 3

Gestational Age-Specific Guidelines

  • For fetal growth restriction with normal umbilical artery Doppler (which this case appears to have based on estimated fetal weight of 2214g at 34 weeks), delivery is recommended at 38-39 weeks 3, 4
  • Immediate delivery at 34 weeks would only be indicated if there were absent or reversed end-diastolic flow in the umbilical artery, which is NOT present in this case 3, 4
  • If CTG deteriorates to Category 3 (abnormal) or if ductus venosus shows reversed A-wave flow, earlier delivery would be warranted 1

Additional Surveillance Recommendations

The following assessments should be performed during the observation period:

  • Serial umbilical artery Doppler every 1-2 weeks to monitor for deterioration 1
  • Middle cerebral artery Doppler to evaluate for brain-sparing physiology, which would indicate worsening placental insufficiency 1
  • Ductus venosus Doppler if CTG abnormalities persist, as reversed A-wave flow is associated with neonatal demise and would prompt delivery 1, 5
  • Daily biophysical profile scoring during inpatient observation 1

Corrected Clinical Impression

The ultrasound findings are appropriate and technically adequate, but the interpretation of Doppler indices as "abnormal" is incorrect. The primary indication for admission is the non-reassuring CTG pattern (decreased variability unresponsive to resuscitation), not abnormal Doppler studies. 2

Key Points for Management

  • Admission for observation is justified based on CTG findings alone 2
  • The plan should emphasize intensive fetal surveillance with daily CTG and serial Doppler studies 2, 3
  • "Possible termination of pregnancy" at 34 weeks is premature unless there is clear evidence of fetal decompensation (Category 3 CTG, reversed ductus venosus flow, or biophysical profile ≤4) 1, 2
  • Antenatal corticosteroids should be administered given the possibility of delivery before 37 weeks 2

Common Pitfalls to Avoid

  • Do not misinterpret borderline-normal Doppler values as pathological, as this leads to unnecessary interventions and iatrogenic prematurity 1
  • Avoid relying solely on CTG without integrating comprehensive Doppler assessment of multiple vessels 1
  • Do not proceed to immediate delivery at 34 weeks based on Category 2 CTG alone without evidence of progressive deterioration 1, 2
  • Ensure repeat CTG assessment occurs within 24 hours, as fetal status can deteriorate rapidly in the setting of placental insufficiency 2, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Category 2 Cardiotocography

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cardiotocography Monitoring Guidelines for Fetal Growth Restriction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Fetal Surveillance in High-Risk Pregnancies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.